David Richman, M.D. studies the biological mechanisms that underlie diseases of the neuromuscular junction with the goal of improving their treatment. He primarily develops animal models of the diseases and test new treatments in this setting. He also assists in clinical trials of these new treatments.
Richman Lab
-
Principal InvestigatorDavid Paul Richman, M.D.
-
Our Research Goals
This lab creates animal models to study diseases affecting the connection between nerves and muscles, aiming to find better treatments. Their work focuses on understanding the immune system and body functions in these diseases.
-
Current Projects
Antigen-specific CAAR T cells to treat rat models of myasthenia gravis
-
Our Team
- Vu Trinh
- Lucia Borges
- Cristien Musson
Clinical Trials
Learn about the different clinical trials we offer.
Giving
Join us to advance neurological health for all.
Fellowship Programs and Training Opportunities
Learn, grow and collaborate with our renowned researchers.